Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Zalicus Is A STRONG BUY

|Includes: AMGN, CVM, EPIRUS Biopharmaceuticals, Inc (EPRS), ESALY, NVS

Zalicus (ZLCS) is a STRONG BUY for these reasons:

Z212 is in development. Z212 is another future candidate.

Z944 go to Phase II clinical study.

Exalgo promise future strong revenues

Prednisporin go to phase III clinical study.

AMGEN (NASDAQ:AMGN), NOVARTIS (NYSE:NOV) and NOW Eisai Co. (OTCPK:ESALY) strong partners!!!!!!!!

Disclosure: I am long ZLCS.